| Product Code: ETC7765780 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Oncology-Cancer Drugs Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 Jordan Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 Jordan Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Jordan Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Jordan Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Jordan |
4.2.2 Advancements in oncology research and technology |
4.2.3 Rising healthcare expenditure and focus on cancer treatment |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for cancer drugs |
4.3.2 High cost of oncology-cancer drugs |
4.3.3 Limited access to advanced cancer treatments in certain regions of Jordan |
5 Jordan Oncology-Cancer Drugs Market Trends |
6 Jordan Oncology-Cancer Drugs Market, By Types |
6.1 Jordan Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 Jordan Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 Jordan Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 Jordan Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Jordan Oncology-Cancer Drugs Market Export to Major Countries |
7.2 Jordan Oncology-Cancer Drugs Market Imports from Major Countries |
8 Jordan Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Patient survival rates after receiving oncology-cancer drugs |
8.2 Adoption rate of novel cancer therapies in Jordan |
8.3 Number of clinical trials for oncology drugs conducted in Jordan |
8.4 Rate of early cancer detection and diagnosis in the population |
8.5 Investment in oncology research and development in Jordan |
9 Jordan Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 Jordan Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Jordan Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Jordan Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 Jordan Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Jordan Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here